Gilead Sciences (NASDAQ:GILD) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 3 | 8 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 3 | 0 | 0 |
| 2M Ago | 0 | 1 | 3 | 0 | 0 |
| 3M Ago | 0 | 1 | 1 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $77.91, along with a high estimate of $95.00 and a low estimate of $70.00. This current average has increased by 2.65% from the previous average price target of $75.90.
Investigating Analyst Ratings: An Elaborate Study
In examining recent analyst actions, we gain insights into...
Login or create a forever free account to read this news
Sign up/Log in